Journey Medical Corp
DERM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867066
No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Journey Medical Corp as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +14 vs. Q3 2021
- Shares held
- 1.63M
- +1.63M vs. Q3 2021
- Total value
- $8.76M
- +$8.76M vs. Q3 2021
- New holders
- 14
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DERM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 71 | $75.2M |
| Q1 2026 | 72 | $55.8M |
| Q4 2025 | 77 | $85.0M |
| Q3 2025 | 68 | $61.9M |
| Q2 2025 | 56 | $46.6M |
| Q1 2025 | 38 | $29.6M |
| Q4 2024 | 37 | $14.8M |
| Q3 2024 | 36 | $12.2M |
| Q2 2024 | 35 | $13.3M |
| Q1 2024 | 33 | $6.68M |
| Q4 2023 | 36 | $7.80M |
| Q3 2023 | 21 | $5.85M |
| Q2 2023 | 20 | $2.63M |
| Q1 2023 | 17 | $2.62M |
| Q4 2022 | 18 | $5.13M |
| Q3 2022 | 20 | $4.62M |
| Q2 2022 | 13 | $6.52M |
| Q1 2022 | 14 | $7.94M |
| Q4 2021 | 14 | $8.76M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Journey Medical Corp; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 656 | $4.00K | 0.00% | +656 | New |
| Royal Bank of Canada | 2,500 | $13.0K | 0.00% | +2,500 | New |
| UBS Group AG | 3,248 | $17.0K | 0.00% | +3,248 | New |
| BlackRock Inc. | 9,328 | $50.0K | 0.00% | +9,328 | New |
| Tudor Investment Corp Et Al | 10,602 | $57.0K | 0.00% | +10,602 | New |
| Citadel Advisors LLC | 10,761 | $58.0K | 0.00% | +10,761 | New |
| B. Riley Wealth Management, Inc. | 15,000 | $81.0K | 0.01% | +15,000 | New |
| Goldman Sachs Group Inc | 35,820 | $193.0K | 0.00% | +35,820 | New |
| Cannell Capital LLC | 41,108 | $221.0K | 0.04% | +41,108 | New |
| Millrace Asset Group, Inc. | 113,862 | $613.0K | 0.36% | +113,862 | New |
| Perkins Capital Management Inc | 140,800 | $758.0K | 0.51% | +140,800 | New |
| American Financial Group Inc | 180,000 | $968.0K | 0.27% | +180,000 | New |
| Neuberger Berman Group LLC | 199,112 | $1.07M | 0.00% | +199,112 | New |
| B. Riley Financial, Inc. | 864,695 | $4.65M | 0.52% | +864,695 | New |